Long COVID-19 in Mildly Symptomatic Patients: Another Vaccine Incentive?

Six months postinfection, young otherwise healthy adults with mild COVID-19 still had excess risk for disruptive dyspnea and cognitive dysfunction. Although long-term sequelae after moderate to severe COVID-19 are well documented, lingering effects in patients with mild COVID-19 have not been as thoroughly investigated. Blomberg et al. conducted a prospective […]